Total Payments
$1,727
2024 Payments
$71.60
Companies
27
Transactions
89
Medicare Patients
1,374
Medicare Billing
$114,659
Payment Breakdown by Category
Food & Beverage$1,727 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,727 | 89 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $575.87 | 32 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $158.20 | 6 | $0 (2023) |
| GlaxoSmithKline, LLC. | $148.26 | 7 | $0 (2023) |
| PFIZER INC. | $102.65 | 6 | $0 (2023) |
| Novo Nordisk Inc | $94.97 | 5 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $89.55 | 4 | $0 (2023) |
| Mylan Specialty L.P. | $62.58 | 3 | $0 (2023) |
| Nestle HealthCare Nutrition Inc. | $62.25 | 3 | $0 (2022) |
| Exact Sciences Corporation | $53.22 | 2 | $0 (2023) |
| Otsuka America Pharmaceutical, Inc. | $53.21 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $71.60 | 3 | ABBVIE INC. ($31.67) |
| 2023 | $616.41 | 30 | ABBVIE INC. ($194.77) |
| 2022 | $631.23 | 33 | ABBVIE INC. ($212.81) |
| 2021 | $407.98 | 23 | AbbVie Inc. ($136.62) |
All Payment Transactions
89 individual payment records from CMS Open Payments — Page 3 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/18/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.76 | General |
| Category: NEUROSCIENCE | ||||||
| 05/16/2022 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $17.33 | General |
| Category: Inflammation | ||||||
| 05/09/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug), SPIRIVA RESPIMAT, SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $27.46 | General |
| Category: RESPIRATORY | ||||||
| 05/04/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $19.51 | General |
| Category: Diabetes | ||||||
| 05/03/2022 | Nestle HealthCare Nutrition Inc. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $22.25 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 04/28/2022 | Alexion Pharmaceuticals, Inc. | STRENSIQ (Biological) | Food and Beverage | In-kind items and services | $23.21 | General |
| Category: Rare Disease | ||||||
| 04/08/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.99 | General |
| Category: NEUROSCIENCE | ||||||
| 04/06/2022 | ABBVIE INC. | CREON (Drug) | Food and Beverage | In-kind items and services | $14.67 | General |
| Category: ENDOCRINOLOGY | ||||||
| 03/30/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $7.36 | General |
| Category: NEUROSCIENCE | ||||||
| 03/10/2022 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $19.54 | General |
| Category: Diabetes | ||||||
| 03/03/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $13.86 | General |
| Category: PRIMARY CARE | ||||||
| 02/22/2022 | PFIZER INC. | PREVNAR 20 (Biological) | Food and Beverage | In-kind items and services | $19.80 | General |
| Category: VACCINES | ||||||
| 02/16/2022 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $18.98 | General |
| Category: Respiratory | ||||||
| 02/02/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.58 | General |
| Category: NEUROSCIENCE | ||||||
| 01/27/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $23.33 | General |
| Category: NEUROSCIENCE | ||||||
| 01/18/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $22.94 | General |
| Category: RESPIRATORY | ||||||
| 12/21/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $23.33 | General |
| Category: NEUROSCIENCE | ||||||
| 12/15/2021 | Nestle HealthCare Nutrition Inc. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $23.80 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 11/30/2021 | Janssen Pharmaceuticals, Inc | INVOKANA (Drug), XARELTO | Food and Beverage | In-kind items and services | $34.09 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/18/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $23.74 | General |
| Category: NEUROSCIENCE | ||||||
| 11/05/2021 | Biohaven Pharmaceuticals, Inc. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $19.59 | General |
| Category: PRIMARY CARE | ||||||
| 10/18/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $19.23 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/12/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.17 | General |
| Category: NEUROSCIENCE | ||||||
| 09/22/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.48 | General |
| Category: NEUROSCIENCE | ||||||
| 09/16/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 489 | 559 | $168,420 | $40,803 |
| 2022 | 10 | 482 | 552 | $161,277 | $43,033 |
| 2021 | 8 | 403 | 454 | $115,860 | $30,823 |
Total Patients
1,374
Total Services
1,565
Medicare Billing
$114,659
Procedure Codes
27
All Medicare Procedures & Services
27 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 152 | 175 | $59,450 | $14,489 | 24.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 75 | 84 | $38,736 | $9,592 | 24.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 152 | 181 | $40,934 | $9,036 | 22.1% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 16 | 16 | $9,410 | $3,103 | 33.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 24 | 24 | $12,216 | $2,632 | 21.5% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 12 | 12 | $4,680 | $1,559 | 33.3% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 23 | 24 | $1,704 | $230.92 | 13.6% |
| 81002 | Urinalysis, manual test | Office | 2023 | 23 | 25 | $750.00 | $85.25 | 11.4% |
| 85610 | Blood test, clotting time | Office | 2023 | 12 | 18 | $540.00 | $75.60 | 14.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 143 | 163 | $54,442 | $12,963 | 23.8% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 45 | 50 | $27,450 | $9,899 | 36.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 54 | 66 | $29,568 | $7,800 | 26.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 126 | 144 | $32,256 | $7,674 | 23.8% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 32 | 34 | $8,670 | $2,173 | 25.1% |
| 99495 | Transitional care management services for problem of moderate complexity | Office | 2022 | 15 | 15 | $5,850 | $2,038 | 34.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 16 | 16 | $1,136 | $151.30 | 13.3% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 13 | 15 | $435.00 | $144.11 | 33.1% |
| 85610 | Blood test, clotting time | Office | 2022 | 19 | 28 | $840.00 | $118.40 | 14.1% |
| 81002 | Urinalysis, manual test | Office | 2022 | 19 | 21 | $630.00 | $72.27 | 11.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 155 | 182 | $40,768 | $10,997 | 27.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 106 | 118 | $39,412 | $10,173 | 25.8% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 37 | 38 | $17,024 | $4,276 | 25.1% |
| 99496 | Transitional care management services, highly complexity, requiring face-to-face visits within 7 days of discharge | Office | 2021 | 20 | 21 | $11,529 | $4,001 | 34.7% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 11 | 11 | $2,805 | $604.12 | 21.5% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 17 | 17 | $2,312 | $522.47 | 22.6% |
About Brendan Ryan, PA-C
Brendan Ryan, PA-C is a Physician Assistant healthcare provider based in Raynham, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/14/2014. The National Provider Identifier (NPI) number assigned to this provider is 1396152187.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Brendan Ryan, PA-C has received a total of $1,727 in payments from pharmaceutical and medical device companies, with $71.60 received in 2024. These payments were reported across 89 transactions from 27 companies. The most common payment nature is "Food and Beverage" ($1,727).
As a Medicare-enrolled provider, Ryan has provided services to 1,374 Medicare beneficiaries, totaling 1,565 services with total Medicare billing of $114,659. Data is available for 3 years (2021–2023), covering 27 distinct procedure/service records.
Ad
Practice Information
- Specialty Physician Assistant
- Location Raynham, MA
- Active Since 07/14/2014
- Last Updated 06/24/2019
- Taxonomy Code 363A00000X
- Entity Type Individual
- NPI Number 1396152187
Products in Payments
- VRAYLAR (Drug) $385.11
- TRELEGY ELLIPTA (Drug) $128.11
- UBRELVY (Drug) $127.24
- XARELTO (Drug) $124.11
- STIOLTO RESPIMAT (Drug) $89.55
- PREVNAR 20 (Biological) $72.99
- ZENPEP (Drug) $62.25
- Ozempic (Drug) $56.80
- Cologuard Collection Kit (Device) $53.22
- REXULTI (Drug) $45.06
- YUPELRI (Drug) $38.72
- INVOKANA (Drug) $34.09
- NOCDURNA (Drug) $33.77
- NURTEC ODT (Drug) $33.45
- CREON (Drug) $31.85
- CAPLYTA (Drug) $31.83
- QULIPTA (Drug) $31.67
- Yupelri (Drug) $23.86
- ABILIFY MAINTENA (Drug) $23.39
- STRENSIQ (Biological) $23.21
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physician Assistant Doctors in Raynham
Mr. Christopher Massey, Pa-C, PA-C
Physician Assistant — Payments: $185,771
Physician Assistant $185,771
Mrs. Lana Savini, Pa-C, PA-C
Physician Assistant — Payments: $460.33
Physician Assistant $460.33
Lauren Martinez, Pa, PA
Physician Assistant — Payments: $150.88
Physician Assistant $150.88
Alaina Annichiarico, Pa-C, PA-C
Physician Assistant — Payments: $63.04
Physician Assistant $63.04
Catherine Green
Physician Assistant — Payments: $36.22
Physician Assistant $36.22
Rebecca Amaral, Pa-C, PA-C
Physician Assistant
Physician Assistant